GGrantIndex
← Search

AGAL-02503: MULTI-CENTER, OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF FABRAZY

$48,090M01FY2005RRNIH

University Of Minnesota Twin Cities, Minneapolis MN

Investigators

Linked publications & trials

View original record on NIH RePORTER →